UnitedHealth Group Incorporated $UNH Shares Purchased by Vident Advisory LLC

Key Points

• Vident Advisory LLC has increased its holdings in UnitedHealth Group by 9.7%, purchasing an additional 7,834 shares, bringing its total to 88,866 shares valued at approximately $46.5 million.
• CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock at an average price of $305, reducing his ownership by 5.36%.
• UnitedHealth Group reported a quarterly EPS of $4.08, missing estimates, and has set its FY 2025 EPS guidance at $16.00.

Vident Advisory LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.7% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 88,866 shares of the healthcare conglomerate's stock after acquiring an additional 7,834 shares during the period. UnitedHealth Group comprises 0.7% of Vident Advisory LLC's investment portfolio, making the stock its 27th biggest holding. Vident Advisory LLC's holdings in UnitedHealth Group were worth $46,545,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Citizens National Bank Trust Department boosted its position in shares of UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock worth $9,368,000 after acquiring an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH boosted its holdings in UnitedHealth Group by 0.3% in the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after purchasing an additional 1,465 shares in the last quarter. Caitlin John LLC raised its holdings in UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate's stock worth $451,000 after purchasing an additional 111 shares in the last quarter. Sherbrooke Park Advisers LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $515,000. Finally, Full Sail Capital LLC raised its stake in UnitedHealth Group by 2.1% during the 4th quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock worth $815,000 after acquiring an additional 33 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the transaction, the chief executive officer directly owned 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.28% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research firms have recently weighed in on UNH. Wolfe Research reduced their target price on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a report on Tuesday, May 20th. TD Cowen lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price on the stock. in a research report on Monday, May 19th. Barclays reiterated an "overweight" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. UBS Group reaffirmed a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, Raymond James Financial lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus target price of $353.00.

UnitedHealth Group Stock Performance

UNH traded up $7.48 during trading on Friday, reaching $309.77. The company's stock had a trading volume of 12,018,847 shares, compared to its average volume of 20,287,358. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company's fifty day moving average price is $288.16 and its 200-day moving average price is $380.68. The company has a market capitalization of $280.55 billion, a price-to-earnings ratio of 13.42, a price-to-earnings-growth ratio of 2.00 and a beta of 0.43. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company's revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.9%. UnitedHealth Group's dividend payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.